Cargando…

mRNA vaccines against SARS-CoV-2: review of non-clinical challenge studies and potential contagiosity in Non Human Primates

Detalles Bibliográficos
Autores principales:	Burbank, M., D’herbe, F., Soares, R., Louin, G., Richard, A., Salomon, V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. Published by Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461778/ http://dx.doi.org/10.1016/S0378-4274(21)00664-0

Ejemplares similares

Contagiosity of Tuberculosis
Publicado: (1891)

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
por: Corbett, Kizzmekia S., et al.
Publicado: (2020)

Intranasal Borna Disease Virus (BoDV-1) Infection: Insights into Initial Steps and Potential Contagiosity
por: Kupke, Alexandra, et al.
Publicado: (2019)

mRNA-1273 vaccination protects against SARS-CoV-2–elicited lung inflammation in nonhuman primates
por: Waickman, Adam T., et al.
Publicado: (2022)

mRNA-1273 Protects against SARS-CoV-2 Beta Infection in Nonhuman Primates
por: Corbett, Kizzmekia S., et al.
Publicado: (2021)

Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection
por: Rappaport, Amy R., et al.
Publicado: (2022)

Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in non-human primates
por: Routhu, Nanda Kishore, et al.
Publicado: (2023)

SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN(®), induces robust humoral and cellular immunity in mice and non-human primates
por: Alimohammadi, Reza, et al.
Publicado: (2022)

Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates
por: Yao, Yan-Feng, et al.
Publicado: (2021)

mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2
por: Jin, Yingqi, et al.
Publicado: (2022)

Challenges and Scientific Prospects of the Newest Generation of mRNA-Based Vaccines against SARS-CoV-2
por: Calina, Daniela, et al.
Publicado: (2021)

Immunogenicity of Low-Dose Prime-Boost Vaccination of mRNA Vaccine CV07050101 in Non-Human Primates
por: van Doremalen, Neeltje, et al.
Publicado: (2021)

Immunogenicity of low dose prime-boost vaccination of mRNA vaccine CV07050101 in non-human primates
por: van Doremalen, Neeltje, et al.
Publicado: (2021)

Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates
por: Prenafeta, Antoni, et al.
Publicado: (2023)

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
por: Jackson, Lisa A., et al.
Publicado: (2020)

Symptomology following mRNA vaccination against SARS-CoV-2
por: Ebinger, Joseph E., et al.
Publicado: (2021)

mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
por: Echaide, Miriam, et al.
Publicado: (2023)

The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2
por: Jamous, Yahya F, et al.
Publicado: (2023)

Bioengineering of Novel Non-Replicating mRNA (NRM) and Self-Amplifying mRNA (SAM) Vaccine Candidates Against SARS-CoV-2 Using Immunoinformatics Approach
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates
por: Marlin, Romain, et al.
Publicado: (2022)

SARS-CoV-2 viral dynamics in non-human primates
por: Gonçalves, Antonio, et al.
Publicado: (2021)

Development of Bivalent mRNA Vaccines against SARS-CoV-2 Variants
por: Li, Jianglong, et al.
Publicado: (2022)

SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies
por: Wijtvliet, Veerle P.W.M., et al.
Publicado: (2022)

A pathogen-like antigen-based vaccine confers immune protection against SARS-CoV-2 in non-human primates
por: Guo, Chang, et al.
Publicado: (2021)

Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates
por: Pavot, Vincent, et al.
Publicado: (2022)

Scleroderma renal crisis following mRNA vaccination against SARS-CoV-2
por: Oniszczuk, Julie, et al.
Publicado: (2021)

Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination
por: Tang, Jinyi, et al.
Publicado: (2022)

Delayed skin reactions and mRNA vaccines against SARS-CoV-2: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Longitudinal monitoring of mRNA-vaccine-induced immunity against SARS-CoV-2
por: Monzon-Posadas, Werner O., et al.
Publicado: (2023)

A novel mRNA vaccine, SYS6006, against SARS-CoV-2
por: Xu, Ke, et al.
Publicado: (2023)

Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
por: Kumari, Monika, et al.
Publicado: (2023)

Comparison of DNA vaccines with AS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2
por: Neeli, Praveen, et al.
Publicado: (2023)

Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates
por: He, Qian, et al.
Publicado: (2022)

Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA–mRNA or Vector–mRNA COVID-19 Vaccines
por: Sølund, Christina, et al.
Publicado: (2022)

Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates
por: Chiuppesi, Flavia, et al.
Publicado: (2022)

A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primates
por: Dalvie, Neil C., et al.
Publicado: (2021)

Passive inhaled mRNA vaccination for SARS-Cov-2
por: Yeo, Wee Song, et al.
Publicado: (2021)

Approved mRNA Vaccines for SARS-CoV-2
por: Faiman, Beth
Publicado: (2021)

Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination
por: Al Jurdi, Ayman, et al.
Publicado: (2022)

Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates
por: Smits, Saskia L., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1gqpq14ludluf3f26q6t13m2i6